PARIS--(BUSINESS WIRE)--Regulatory News:Orano Med (Orano group subsidiary), a leading innovator in the field of Targeted Alpha Therapies in oncology, is thrilled to announce the appointment of Dr. Volker Wagner MD PhD as its new Chief Medical Officer. Dr. Wagner brings a wealth of experience and expertise to the rol...
Related Keywords
United States , Julien Dodet , Head Of Clinical Development Radiopharmaceuticals At Bayer , Clinical Development , Regulatory News , Targeted Alpha Therapies , Volker Wagner , Chief Medical , Vice President , Clinical Development Radiopharmaceuticals , Targeted Alpha , Medical Affairs , Internal Medicine , Medical Oncology , Orano Med ,
comparemela.com © 2020. All Rights Reserved.